文献速递银屑病与炎症性皮肤病

儿童青少年银屑病患者随访至成年早期的治疗持续性:从外用治疗到系统治疗的前瞻性纵向观察队列研究

Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observational cohort study of 448 patients.
PubMed 文献 · Br J Dermatol · 2020-07-29

该研究基于Child-CAPTURE登记库,纳入448例儿童期发病的银屑病患者并随访至成年早期。更高的PASI和DLQI>5与转为系统治疗独立相关。

要点

  • 约三分之一儿童青少年银屑病患者需超越单纯外用的强化治疗。
  • PASI升高和DLQI>5与转为系统治疗独立相关。

核心结论

  • 在儿童和青少年轻至重度银屑病患者中,约三分之一需要比单纯外用更强化治疗以控制疾病。
  • 研究者认为从发病至转为系统治疗的中位时间偏长。

研究设计与样本

  • 数据来自Child-CAPTURE登记库,为2008至2018年前瞻性观察队列,纳入儿童期发病并随访至成年早期的银屑病患者。
  • 纳入登记前数据通过回顾性方式收集,共448例患者。
  • 中位时间通过Kaplan-Meier生存分析确定,Cox回归分析用于识别与转为系统治疗相关的患者特征。

关键数值与推荐

  • 更高的银屑病面积和严重程度指数(PASI)与转为系统治疗独立相关。
  • (儿童)皮肤病生活质量指数((Children's) DLQI)>5与转为系统治疗独立相关。

临床怎么用

  • 对儿童青少年银屑病患者应评估PASI和DLQI,以识别可能需要系统治疗的高风险患者。
  • 单纯外用治疗持续时间较长,临床需关注疾病控制不足时及时升级治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although solely topical treatment often suffices, patients with psoriasis may require more intensive treatment (phototherapy and/or systemic treatments) to control their disease. However, in paediatric, adolescent and young adult patients, little is known about persistence of topical treatment and time until switch to systemic treatment. OBJECTIVES: To determine the median time from psoriasis onset until (i) discontinuation of solely topical agents and (ii) switch to systemic treatment, and to identify patient characteristics associated with switching to systemic treatments. METHODS: Data were extracted from the Child-CAPTURE registry, a prospective, observational cohort of patients with paediatric-onset psoriasis followed into young adulthood from 2008 to 2018. Data prior to inclusion in the registry were collected retrospectively. Median times were determined through Kaplan-Meier survival analyses. Cox regression analysis was used to identify patient characteristics associated with switch to systemic treatment. RESULTS: Of 448 patients, 62·3% stayed on solely topical treatment until data lock; 14·3% switched from topicals to phototherapy, but not to systemic treatment; and 23·4% switched to systemic treatment. The median time from psoriasis onset until discontinuation of solely topical treatment was 7·3 years, and until switch to systemics was 10·8 years. Higher Psoriasis Area and Severity Index and (Children's) Dermatology Life Quality Index > 5 were independently associated with switching to systemic treatment. CONCLUSIONS: In a population of paediatric and adolescent patients with mild-to-severe psoriasis, one-third needed more intensive treatment than solely topical therapy to control their disease. We consider the median time until switching to systemics to be long.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Bruins FM, Bronckers IMGJ, Cai R, et al. Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observational cohort study of 448 patients. Br J Dermatol. 2020. PMID: 32510578. doi:10.1111/bjd.19301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。